17 June 2021
: Case report 
SARS-CoV-2-Related Subacute Thyroiditis, Myocarditis, and Hepatitis After Full Resolution of COVID-19 Serum Markers
Unusual clinical course
Alejandra Osorio Martínez1BEF, Victoria Taís González-Razo1BEF, Valeria Navarro-Sánchez1BEF, Carlos A. Souto Meiriño2CD, Miguel Ahumada-Ayala13BDEF*DOI: 10.12659/AJCR.932321
Am J Case Rep 2021; 22:e932321
Table 1. Summarizes all blood tests, obtained results, and their respective reference values.
| Test | Results | Reference Values |
|---|---|---|
| 13.3 g/dl | 14–18 g/dl | |
| 38.5% | 42–54% | |
| 6.5×10/μL | 3.8–11.2×10/μL | |
| 141×10/μL | 130–400×10/μL | |
| 1,496.52 ng/ml | 21.81–274.66 ng/ml | |
| 109 mg/dl | 70–100 mg/dl | |
| 18.6 mg/dl | 5–25 mg/dl | |
| 0.71 mg/dl | 0.6–1.6 mg/dl | |
| 3.73 g/dl | 3.5–5.0 g/dl | |
| 2.71 g/dl | 2.5–4.0 g/dl | |
| 8.9 mg/dl | 8.4–10.2 mg/dl | |
| 3.72 mg/dl | 2.2–4.5 mg/dl | |
| 140 mEq/L | 135–145 mEq/L | |
| 4.1 mEq/L | 3.5–5.3 mEq/L | |
| 108 mEq/L | 95–114 mEq/L) | |
| 21.3 mEq/L | 20–31mEq/L | |
| 0.76 mg/dl | 0.0–1.5 mg/dl | |
| 185 U/L | 40–150 U/L | |
| 194.6 U/L | 6–66 U/L | |
| 93.4 U/L | 9–55 U/L | |
| 190.9 U/L | 15–73 U/L | |
| 176 U/L | 125–243 U/L | |
| 96 U/L | 30–200 U/L | |
| 38 U/L | 5.0–25 U/L | |
| 643.4 ng/dl | 35–193 ng/dl | |
| 12.0 μg/dl | 4.8–11.7 μg/dl | |
| 1.85 ng/dl | 0.7–1.48 ng/dl | |
| 0.01 μIU/ml | 0.35–4.94 μlU/ml | |
| 0.0–34.2 pg/ml | ||
| cOn admission 548.3 pg/ml | ||
| was positive: titer 36.85 AU/ml | Positive >1 AU/ml | |
| 17 IU/ml | <84 IU/ml | |
| 15 IU/ml | <34 IU/ml | |
| 0.56 | <1 IU/ml | |